AGP Picks
View all

Latin America Health Times
Provided by AGP

Latin America Health Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Latin America Health Times.

August 2026

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

September 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30

October 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

Press releases published on September 29, 2026

Celularity Announces Naveen Jain to Join Board of Directors
Sep. 29, 2026

Celularity Announces Naveen Jain to Join Board of Directors

Indeterminate GlobeNewswire
TOMI Environmental Solutions Targets Next Phase of Growth in the Scaling Robotaxi, Drone and Robotics Economy
Sep. 29, 2026

TOMI Environmental Solutions Targets Next Phase of Growth in the Scaling Robotaxi, Drone and Robotics Economy

Indeterminate GlobeNewswire
J-Star Holding Co., Ltd. Chairman and CEO Jonathan Chiang to Relocate to the United States to Lead Growth Initiatives
Sep. 29, 2026

J-Star Holding Co., Ltd. Chairman and CEO Jonathan Chiang to Relocate to the United States to Lead Growth Initiatives

Indeterminate GlobeNewswire
AI-Powered Liquid Biopsy Emerges as a High-Stakes Frontier in Precision Oncology, Attracting Hundreds of Millions in Venture and Public Funding
Sep. 29, 2026

AI-Powered Liquid Biopsy Emerges as a High-Stakes Frontier in Precision Oncology, Attracting Hundreds of Millions in Venture and Public Funding

Indeterminate GlobeNewswire
Telitacicept Demonstrates Deep and Durable Minimal Symptom  Expression Through 48 Weeks in Generalized Myasthenia Gravis
Sep. 29, 2026

Telitacicept Demonstrates Deep and Durable Minimal Symptom  Expression Through 48 Weeks in Generalized Myasthenia Gravis

Indeterminate GlobeNewswire
Silexion Therapeutics Announces Exercise of Warrants
Sep. 29, 2026

Silexion Therapeutics Announces Exercise of Warrants

Indeterminate GlobeNewswire
BIO-Europe 2026 to Convene Global Biopharma Decision-Makers in Cologne
Sep. 29, 2026

BIO-Europe 2026 to Convene Global Biopharma Decision-Makers in Cologne

Indeterminate GlobeNewswire
argenx Presents New Data at AANEM and MGFA Scientific Session Showcasing Earlier and Sustained Treatment in MG and CIDP with VYVGART and Progress Across its Neuromuscular Pipeline
Sep. 29, 2026

argenx Presents New Data at AANEM and MGFA Scientific Session Showcasing Earlier and Sustained Treatment in MG and CIDP with VYVGART and Progress Across its Neuromuscular Pipeline

Indeterminate GlobeNewswire
Keros Therapeutics to Receive Additional Development Milestone Payment from Partner Takeda
Sep. 29, 2026

Keros Therapeutics to Receive Additional Development Milestone Payment from Partner Takeda

Indeterminate GlobeNewswire
Dianthus Therapeutics Highlights Claseprubart Data Presentations Planned for 2026 AANEM Annual Meeting
Sep. 29, 2026

Dianthus Therapeutics Highlights Claseprubart Data Presentations Planned for 2026 AANEM Annual Meeting

Indeterminate GlobeNewswire
Nasus Pharma Announces Enrollment and Dosing of First Patient in Phase 1 Study of NS003 Intranasal Formulation of Ondansetron
Sep. 29, 2026

Nasus Pharma Announces Enrollment and Dosing of First Patient in Phase 1 Study of NS003 Intranasal Formulation of Ondansetron

Indeterminate GlobeNewswire
DiFusion to Define Therapeutic Biomaterials Category at NASS 2026
Sep. 29, 2026

DiFusion to Define Therapeutic Biomaterials Category at NASS 2026

Indeterminate GlobeNewswire
Illume Fertility Advances Access to LGBTQ+ Family Building at Men Having Babies New York Annual Conference
Sep. 29, 2026

Illume Fertility Advances Access to LGBTQ+ Family Building at Men Having Babies New York Annual Conference

Indeterminate GlobeNewswire
Beta Bionics to Announce Third Quarter 2026 Financial Results on October 27, 2026
Sep. 29, 2026

Beta Bionics to Announce Third Quarter 2026 Financial Results on October 27, 2026

Indeterminate GlobeNewswire
Pentagon Pivots on Havana Syndrome with Re-Branding, Compensation, and a New Study
Sep. 29, 2026

Pentagon Pivots on Havana Syndrome with Re-Branding, Compensation, and a New Study

Indeterminate GlobeNewswire
Weight Watchers and Google Health Enterprise Launch New Collaboration to Enhance Engagement and Outcomes in Weight Health Programs
Sep. 29, 2026

Weight Watchers and Google Health Enterprise Launch New Collaboration to Enhance Engagement and Outcomes in Weight Health Programs

Indeterminate GlobeNewswire
Phathom Pharmaceuticals Announces Initiation of Registrational Phase 3 Study of VOQUEZNA® (vonoprazan) for As-Needed Treatment of Non-Erosive GERD
Sep. 29, 2026

Phathom Pharmaceuticals Announces Initiation of Registrational Phase 3 Study of VOQUEZNA® (vonoprazan) for As-Needed Treatment of Non-Erosive GERD

Indeterminate GlobeNewswire
Noah Medical’s Galaxy System Enters Commercial Use in Asia with First Procedure Completed in Hong Kong
Sep. 29, 2026

Noah Medical’s Galaxy System Enters Commercial Use in Asia with First Procedure Completed in Hong Kong

Indeterminate GlobeNewswire
Apyx Medical Announces New Clinical Study Demonstrating Renuvion®’s Impact on Skin Quality
Sep. 29, 2026

Apyx Medical Announces New Clinical Study Demonstrating Renuvion®’s Impact on Skin Quality

Indeterminate GlobeNewswire
NewAmsterdam Pharma Doses First Participant in Phase 2b SPINOZA Trial Evaluating Obicetrapib in Preclinical Alzheimer’s Disease
Sep. 29, 2026

NewAmsterdam Pharma Doses First Participant in Phase 2b SPINOZA Trial Evaluating Obicetrapib in Preclinical Alzheimer’s Disease

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Latin America Health Times

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.